Breaking News
Start for Free 0
🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One Click COPY FOR FREE
Close

Yakult Honsha Co Ltd (2267)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,096.0 +12.0    +0.39%
12/09 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3931600005 
  • Volume: 1,191,500
  • Bid/Ask: 3,094.0 / 3,098.0
  • Day's Range: 3,062.0 - 3,118.0
Yakult Honsha Co Ltd 3,096.0 +12.0 +0.39%

Yakult Honsha Co Ltd Company Profile

 
Get an in-depth profile of Yakult Honsha Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryFood & Tobacco
SectorConsumer Non-Cyclicals
Employees

29273

Equity Type

ORD

YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.

Contact Information

Address 10-30, Kaigan, 1-chome Minato-ku
Tokyo, 105-8660
Japan
Phone 81 3 6625 8960
Fax -

Top Executives

Name Age Since Title
Masatoshi Nagira - 2023 Managing Executive Officer & Director
Sumiya Hori - 2011 Honorary Chairman & Consultant
Satoko Kitamura - 2024 Outside Auditor
Kimikazu Okochi - 2024 Outside Auditor
Yoshiaki Onozuka - 2024 Auditor
Koichi Hirano 70 2017 Senior Managing Executive Officer, GM of Research and Development Division & Director
Hideaki Hoshiko 66 2019 Senior Managing Executive Officers, GM of Administration Headquarters & Director
Hiroshi Narita 73 2007 Chairman, President & Executive Officer
Shuichi Watanabe 67 2024 Managing Executive Officer, GM of Pharmaceutical Business Headquarters & Director
Emi Machida 60 2020 Outside Audit & Supervisory Board Member
Junichi Shimada 64 2022 Managing Executive Officer, GM of International Business Headquarters & Director
Hideyuki Kawana 64 2020 Senior Audit & Supervisory Board Member
Yasuyuki Suzuki 68 2024 Managing Executive Officer, Divisional GM of Production Division & Director
Hiroyuki Kawabata 66 2024 Managing Executive Officer, Divisional GM of Management Support Division & Director
Yumiko Nagasawa 65 2021 Independent Outside Director
Naoko Tobe 67 2019 Independent Part-Time Outside Director
Satoshi Akutsu 58 2022 Independent Outside Director
Katsuyoshi Shinbo 69 2021 Independent Outside Director
Matthew Digby 73 2023 Independent Outside Director
Manabu Naito 64 2022 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

2267 Comments

Write your thoughts about Yakult Honsha Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email